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Salt-Sensitivity
Mononuclear Phagocyte System Depletion Blocks Interstitial
Tonicity-Responsive Enhancer Binding Protein/Vascular
Endothelial Growth Factor C Expression and Induces
Salt-Sensitive Hypertension in Rats
Agnes Machnik, Anke Dahlmann, Christoph Kopp, Jennifer Goss, Hubertus Wagner,
Nico van Rooijen, Kai-Uwe Eckardt, Dominik N. Mu¨ller, Joon-Keun Park, Friedrich C. Luft,
Dontscho Kerjaschki, Jens Titze
Abstract—We showed recently that mononuclear phagocyte system (MPS) cells provide a buffering mechanism for
salt-sensitive hypertension by driving interstitial lymphangiogenesis, modulating interstitial Na clearance, and increasing
endothelial NO synthase protein expression in response to very high dietary salt via a tonicity-responsive enhancer binding
protein/vascular endothelial growth factor C regulatory mechanism. We now tested whether isotonic saline and deoxycorti-
costerone acetate (DOCA)-salt treatment leads to a similar regulatory response in Sprague-Dawley rats. Male rats were fed
a low-salt diet and received tap water (low-salt diet LSD), 1.0% saline (high-salt diet HSD), or DOCA1.0% saline
(DOCA-HSD). To test the regulatory role of interstitial MPS cells, we further depleted MPS cells with clodronate liposomes.
HSD and DOCA-HSD led to Na accumulation in the skin, MPS-driven tonicity-responsive enhancer binding protein/
vascular endothelial growth factor C–mediated hyperplasia of interstitial lymph capillaries, and increased endothelial NO
synthase protein expression in skin interstitium. Clodronate liposome MPS cell depletion blocked MPS infiltration in the skin
interstitium, resulting in unchanged tonicity-responsive enhance binding protein/vascular endothelial growth factor C levels
and absent hyperplasia of the lymph capillary network. Moreover, no increased skin endothelial NO synthase protein
expression occurred in either clodronate liposome–treated HSD or DOCA-salt rats. Thus, absence of the MPS-cell regulatory
response converted a salt-resistant blood-pressure state to a salt-sensitive state in HSD rats. Furthermore, salt-sensitive
hypertension in DOCA-salt rats was aggravated. We conclude that MPS cells act as onsite controllers of interstitial volume
and blood pressure homeostasis, providing a local regulatory salt-sensitive tonicity-responsive enhancer binding protein/
vascular endothelial growth factor C–mediated mechanism in the skin to maintain normal blood pressure in states of interstitial
Na and Cl accumulation. Failure of this physiological extrarenal regulatory mechanism leads to a salt-sensitive blood
pressure response. (Hypertension. 2010;55:755-761.)
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Traditionally, researchers focus on the kidney, the brain,the heart, the adrenal gland, or the blood vessels to
explain the pathogenesis of hypertension.1 A recent dietary
intervention study suggested that refractory hypertension is
eminently salt sensitive.2 Salt-sensitive hypertension is com-
monly believed to be a “renal affair.” The prevailing view on
the causal relationship among salt intake, total body Na and
fluid balance, and blood pressure (BP) follows the basic
notion that extracellular bodily fluids are in equilibrium,3–5
that the kidney controls total body Na content and thereby
the extracellular volume exclusively, and that increases in
extracellular volume lead to increased BP.6,7 The underlying
concept of extracellular Na, volume, and BP homeostasis
controlled by the kidney relies on the idea that interstitial Na
is readily equilibrated with plasma Na, can be easily
mobilized into the bloodstream, and that the kidneys control
interstitial Na and volume indirectly by means of blood
purification.
In earlier studies, we questioned the widely accepted view
that extracellular fluids are in equilibrium. We found instead
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that Na is stored in the skin, with higher concentrations
compared to blood, in animals fed a high-salt diet (HSD).8–11
Recently, we showed that interstitial mononuclear phagocyte
system (MPS) cells act as such extrarenal regulators of
interstitial Na and water homeostasis.12 We experimentally
induced hypertonic Na storage in the skin and interstitial
MPS infiltration. In response to Na-mediated osmotic stress,
MPS cells activated tonicity-responsive enhancer binding
protein (TonEBP), which binds to the vascular endothelial
growth factor (VEGF) C (VEGF-C) gene. By commanding
VEGF-C expression, the MPS response to osmotic stress via
TonEBP results in increased density and hyperplasia of the
lymph-capillary network in the interstitium and in increased
protein expression of endothelial NO synthase (eNOS) in
interstitial cells.
In our earlier study, we induced hypertonic Na accumu-
lation, which activates the TonEBP/VEGF-C–driven regula-
tory cascade in MPS cells by subjecting rats to an 8% salt diet
plus 0.9% sodium chloride in drinking water. Other than the
compensatory MPS-driven changes in lymph capillary struc-
ture and eNOS expression, such massive dietary salt loading
led to salt-sensitive hypertension in Sprague-Dawley rats.
Additional experimental depletion of the MPS cells or block-
ade of VEGF-C with its receptors VEGF receptor 3 and/or
VEGF receptor 2 blocked the regulatory response of MPS
cells to interstitial Na accumulation and augmented salt-
sensitive hypertension, suggesting that MPS cells provide a
buffering mechanism for hypertension.12
Here we asked whether our initial findings were restricted
to an experimental approach with massive dietary salt loading
only or whether more moderate dietary salt loading with 1.0%
saline in drinking water, a challenge that does not usually
increase BP in Sprague-Dawley rats, leads to MPS infiltration
and activation of the TonEBP/VEGF-C regulatory axis in the
skin. Furthermore, we speculated that blockade of this com-
pensatory interstitial MPS response might convert the rats
from a salt-resistant to a salt-sensitive state. Finally, this
study represents the first test of role of MPS on volume and
BP homeostasis in rats with deoxycorticosterone actetate
(DOCA) treatment and 1.0% saline in drinking water. In
earlier studies, we had shown that this model features
salt-sensitive hypertension associated with Na storage in the
skin.9,13,14
Methods
Animal Experiments
Local government authorities approved the studies and the experi-
ments, according to internationally accepted criteria. We randomly
assigned male Sprague-Dawley rats aged 8 to 9 weeks to 6 groups:
groups 1 and 2 were assigned to a low-salt diet (LSD; 0.1% NaCl)
and tap water. Groups 3 through 6 were also fed a low-salt chow
(0.1% NaCl) but received salt loading by 1.0% saline water to
drink (HSD). Groups 5 and 6 were additionally treated with 100-mg
DOCA acetate pellets SC (DOCA-HSD). To assess the role of MPS
cells in the control of volume and BP homeostasis, groups 2, 4, and
6 received clodronate liposomes (Clod) IP every 72 hours for MPS
depletion.12,15 Two days before the end of the experiment, we placed
the rats in a metabolic cage and sampled urine for 24 hours. At the
end of both rat experiments after 2 weeks on their specified diets, we
anesthetized the rats with 1.5% to 2.0% isoflurane anesthesia and
catheterized the right femoral artery. We connected arterial lines to
MLT0380/A transducers and a PowerLab 8/30 data acquisition
system (ADInstruments) and measured arterial BP in conscious
animals kept in a restrainer 2 hours after the operation; thereafter,
blood samples were taken, the animals were killed, and skin and ear
samples were taken for histology and assessment of protein and gene
expression. We analyzed arterial blood gases with a clinical blood
gas analyzer (Radiometer Copenhagen), including Na, K, and Cl
measurements by ion-selective electrodes. Chemical analysis of the
carcasses included Na, K, Cl, and water measurements after dry
ashing of the different tissues as reported previously.8,10 We calcu-
lated the Cl space as a measure of the extracellular volume from the
tissue Cl content and the serum Cl concentration. The Cl-free
water space was calculated as a measure of the intracellular volume.
Detailed information on the ashing protocol is provided in the online
Data Supplement (please see http://hyper.ahajournals.org).
Immunohistochemistry and Immunofluorescence
Staining of MPS Cells and Lymphcapillaries
We performed all of the staining using the Avidin/Biotin Blocking
kit (Vector Laboratories) and horseradish peroxidase super staining
kit (ID Laboratories) according to the manufacturer’s instructions
(please see the online Data Supplement). After staining with specific
antibodies, lymph capillaries (anti-podoplanin antibody, from D. K.),
MPS cells (anti-CD68 antibody, MCA1029, AbD Serotec), and
VEGF-C–positive cells (anti–VEGF-C, ab9546, Abcam) were
counted throughout the whole diameter of a crosswise cut rat ear. We
counted lymphcapillaries in 5 consecutive sections and MPS and
VEGF-C–positive cells in 6 consecutive sections and normalized
capillary and cell counts per field.
Immunofluorescence of Endothelial NO
Synthase Expression
We performed indirect immunofluorescence for expression of endo-
thelial NO synthase (eNOS) in the ear with a rabbit polyclonal
anti-eNOS antibody (PA1–037, Affinity BioReagents), as reported
previously.12 We analyzed specimens using a Zeiss Axioplan-2
imaging microscope with the digital image processing program
AxioVision 4.3 (Zeiss).
TonEBP, VEGF-C, and Tumor Necrosis Factor-
Gene and Protein Expression
We quantified mRNA expression in skin samples by real-time PCR,
as reported previously (please see the online Data Supplement for
details on primer sequences).12 VEGF-C protein expression in skin
samples was quantified by Western blot analysis (VEGF-C–specific
antibody, ab9546, Abcam). Serum tumor necrosis factor (TNF)-
levels were measured by ELISA, according to the manufacturer’s
instructions (Abcam).
Statistical Analysis
Comparison of means of data from animal experiments was calcu-
lated by multivariate or univariate analysis using the generalized
linear measurements procedure. We tested for the effect of diet,
DOCA treatment, and Clod treatment. All of the data in the article
are presented as averageSD. Statistical analysis was performed
with the SPSS software (version 17.0).
Results
Experimental MPS Depletion Induces Salt
Sensitivity in Rats
BP in the rats did not increase with HSD (Figure 1A).
However, BP increased when HSD rats were given Clod; the
BP increase was composed of10 mm Hg. In LSD rats, Clod
did not increase BP. These findings suggest that MPS
depletion with Clod indeed blocked a compensatory mecha-
nism to maintain basal BP in HSD-treated rats. DOCA-HSD
rats developed salt-sensitive hypertension that was paralleled
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by increased skin Cl content and extracellular volume
(ECV) retention in the skin (Figure 1A and 1B). Adding Clod
increased BP and Cl and extracellular volume retention in
the skin further. These findings suggest that salt-sensitive
hypertension in DOCA-HSD rats was paralleled by electro-
lyte and volume retention in the rats and that MPS depletion
with Clod further augmented hypertension and volume reten-
tion in the skin.
Other than the dramatic changes in body electrolyte and
water composition, DOCA treatment is known to induce an
inflammatory state. Accordingly, DOCA-HSD and DOCA-
HSD-plus-Clod–treated rats exhibited less weight gain (Ta-
ble) and showed tissue Na retention, water retention, and
tissue K loss (Table), as well as hypokalemia, metabolic
alkalosis (Table), increased serum TNF- levels, and in-
creased TNF- mRNA expression in the skin (Figure 1C).
This inflammatory response was paralleled by proteinuria in
the DOCA-HSD rats, which was aggravated by Clod. In
contrast to DOCA-HSD hypertension, the de novo salt
sensitivity induced in HSD rats by Clod treatment was
paralleled solely by a modest increase in urinary protein
excretion (Table) and no increase in TNF- expression.
Salt Loading Induces MPS/TonEBP/VEGF-C–
Driven Lymphocapillary Network Hyperplasia
and Increases eNOS Expression
HSD and DOCA-HSD increased interstitial MPS and VEGF-
C–positive cells in the cutaneous interstitium of the rat ear
(Figure 2A and Figure S2 in the online Data Supplement,
please see http://hyper.ahajournals.org). The MPS accumula-
tion with HSD and with DOCA-HSD was accompanied by
slight Na accumulation without a detectable increase in
water content in the skin in HSD rats and by pronounced Na
and water retention in the skin in DOCA-HSD rats (Table).
Skin Na accumulation in rats with HSD alone and in
DOCA-HSD rats led to an increased Na:water ratio in the
skin (Table) and was paralleled by increased mRNA expres-
sion of TonEBP in the skin (Figure 2B), where the
(NaK):water ratio was significantly higher than in
plasma (Table). This state of affairs suggests that osmotic
stress is a critical feature in this cutaneous interstitium
microenvironment accumulating salt. TonEBP induces
VEGF-C expression. Consequently, both HSD and DOCA-
HSD increased VEGF-C mRNA (Figure 2B) and the
VEGF-C protein expression in the skin (Figure 3). Activation
of the TonEBP/VEGF-C regulatory axis was paralleled by
increased podoplanin mRNA expression, which is a marker
protein of lymph endothelial cells (Figure 2B), and was
associated with hyperplasia of the lymph-capillary network in
HSD and DOCA-HSD rats (Figure 2A and Figure S3),
featuring increased interstitial lymph capillary count in rat ear
samples. Furthermore, increased TonEBP/VEGF-C levels
were paralleled by increased eNOS protein expression in the
skin (Figure 4A), which did not colocalize with the lymph
capillary network (Figure 4B), indicating that the lymph
endothelium was not a source of increased capillary eNOS
expression, suggesting that increased eNOS protein expres-
sion with HSD or DOCA-HSD originated from blood capil-
lary endothelial cells.
Experimental MPS Depletion Prevents the
Interstitial Compensatory Response to Dietary Salt
Clod effectively depleted MPS cells into the cutaneous
interstitium (Figure 2A and Figure S2). In both HSD rats and
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Figure 1. A, Mean arterial blood pressure (MAP) and Cl con-
tent in skin at the end of the study in rats with LSD diet (0.1%
NaCl chow and tap water) or HSD diet (0.1% NaCl chow and
1.0% saline water), with or without Clod and/or DOCA treatment
for 2 weeks. Clodronate treatment induced salt-sensitivity in
untreated rats and deteriorated hypertension in DOCA-salt rats.
B, Chloride space and chloride-free space measurements as
estimates for extracellular volume (ECV) and intracellular volume
(ICV) in the skin. DOCA HSD increased ECV in the rats, and
additional Clod treatment increased ECV further in DOCA HSD
rats, but not with HSD alone. C, Serum TNF- level and TNF-
gene expression in the skin. DOCA HSD treatment, but not HSD
alone, increased both TNF- protein and gene expression in
parallel with salt-sensitive hypertension. *P0.05 vs LSD;
#P0.05 vs LSD Clod; †P0.05 vs HSD; ‡P0.05 vs HSD
Clod; §P0.05 vs DOCA HSD; $P(DOCA*Clod)0.05.
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DOCA-HSD rats, experimental MPS depletion with Clod
blocked infiltration of VEGF-C–positive MPS cells into the
cutaneous interstitium (Figure 2A). In parallel, MPS deple-
tion in HSD and DOCA-HSD rats reduced TonEBP and
VEGF-C mRNA expression (Figure 2B), as well as VEGF-C
protein expression (Figure 3) in the skin, to control levels. In
the absence of the TonEBP/VEGF-C response in HSD and
DOCA-HSD rats with MPS depletion, the rats no longer
showed hyperplasia of the lymph capillary network in the
skin (Figure 2A and Figure S3), and eNOS protein expression
was reduced to the control level (Figure 4). In DOCA-HSD
rats, absence of hyperplasia of the lymphocapillary net-
work was paralleled by further interstitial Cl (Figure 1A)
and volume retention (Figure 1B), as well as further BP
increase. These findings suggest that MPS cells are re-
quired to maintain BP at low levels in states of NaCl
accumulation. MPS cells either induce hyperplasia of the
lymph capillary network, which facilitates mobilization of
interstitial volume, or increase eNOS protein expression in
response to isotonic dietary salt loading and provide a
Table. Body and Tissue Electrolyte and Water Analysis, Blood Gas Analysis, and Urinary Protein Excretion
Parameter LSD LSD and Clod HSD HSD and Clod DOCA-HSD DOCA-HSD and Clod
Body and tissue weights
BW start, g 278.013.2 272.619.6 277.916.9 278.213.5 276.39.6 277.313.9
BW end, g 359.322.2 342.221.8 361.020.2 355.620.4 342.123.6 343.426.9
BW, g 81.415.6 69.64.7 83.114.2† 77.515.5 65.818.3‡ 66.11.9‡
WW, g 305.021.0 286.722.0 300.516.5 298.520.1 281.723.3*‡ 284.024.4
DW, g 101.08.1 94.28.9 97.28.2 97.66.3 88.48.6*‡§ 87.29.5*‡§
Skin WW, g 62.97.8 58.55.9 61.24.4 61.45.2 54.55.0*‡§ 56.16.6*‡§
Skin DW, g 25.23.1 23.02.5 23.52.6 23.91.8 20.62.2*‡§ 20.32.9*‡§
Body and tissue electrolyte and water
content
Total body Na, mmol/g DW 0.1570.013 0.1620.005 0.1660.011 0.1630.010 0.1990.009*†‡§ 0.2050.013*†‡§
Total body K, mmol/g DW 0.2020.013 0.2000.015 0.2110.014 0.2080.015 0.1860.007*†‡§ 0.1870.010*‡§
Total body water, mL/g DW 2.0230.111 2.0490.073 2.0990.120 2.0610.101 2.1920.068*†‡§ 2.2670.107*†‡§
Skin Na, mmol/g DW 0.1540.018 0.1620.011 0.1770.018* 0.1710.014* 0.1930.016*†‡§ 0.2090.024*†‡§¶
Skin K, mmol/g DW 0.1040.007 0.1060.007 0.1070.006 0.1040.009 0.0970.009‡ 0.0960.008*†‡
Skin water, mL/g DW 1.5060.189 1.5480.057 1.6140.119 1.5750.116 1.6530.088*† 1.7700.129*†‡§¶
Skin Na/skin water, mmol/mL 0.1030.005 0.1050.003 0.1090.004*† 0.1080.004* 0.1170.010*†‡§ 0.1180.005*†‡§
Skin, NaK/skin water, mmol/mL 0.1720.010 0.1730.004 0.1760.004 0.1740.007 0.1760.011 0.1720.004
Blood gas analysis, plasma electrolytes,
and urinary protein excretion
pH 7.470.04 7.480.02 7.470.02 7.470.02 7.550.02*†‡§ 7.550.02*†‡§
PO2, mm Hg 87.07.6 85.411.1 86.14.5 84.86.6 80.88.3 79.86.5*‡
PCO2, mm Hg 37.74.0 38.22.9 37.62.1 38.12.5 42.43.0*†‡§ 41.12.8*‡§
Plasma Na, mmol/L 139.21.2 139.41.3 140.01.8 140.11.3 142.21.7*†‡§ 141.41.9*†
Plasma K, mmol/L 4.280.32 4.210.36 4.180.36 4.170.37 2.250.25*†‡§ 2.290.18*†‡§
Plasma Cl, mmol/L 104.10.7 102.52.2 103.42.6 103.10.6 95.31.6*†‡§ 94.31.7*†‡§
Plasma HCO3
, mmol/L 27.60.5 28.30.9 27.61.1 27.90.8 36.21.4*†‡§ 36.01.6*†‡§
Anion gap, mmol/L 7.91.3 8.91.7 9.61.6* 9.51.2* 10.21.5* 10.80.8*†‡§
Urinary protein, mg/d 18.25.1 16.14.7 22.54.3*† 23.57.3† 47.320.1*†‡§ 199.7164.6*†‡§¶
In the body and tissue weights section, data show the in vivo body weight (BW) at the begin and end of the study, total carcass body weight (WW) and dry weight
(DW) at the end of the study, skin wet (SKWW), and dry weight (SKDW) at the end of the study in rats with LSD diet (0.1% NaCl chow and tap water) or HSD diet
(0.1% NaCl chow and 1.0% saline water), with or without Clod and DOCA treatment for 2 weeks. DOCA-salt treatment reduced body and skin DW, indicating growth
retardation, whereas HSD and HSD Clod had no effect on body weight. In the body and tissue electrolyte and water content section, data show the total body and
skin electrolyte and water content in the rats. HSD alone and HSD Clod did not increase electrolyte and water contents in the rats. DOCA treatment increased Na
and water content in the body and in the skin. Na and water contents were highest in DOCA HSD rats with additional Clod. In the blood gas analysis, plasma
electrolytes, and urinary protein excretion section, both DOCA HSD and DOCA HSD Clod led to hypochloremic and hypokalemic metabolic alkalosis, whereas HSD and
HSD Clod did not. HSD slightly increased urinary protein excretion, and DOCA HSD increased proteinuria further. Additional Clod treatment exacerbated proteinuria
in DOCA HSD rats but not in rats with HSD alone.
*P0.05 vs LSD.
†P0.05 vs LSD Clod.
‡P0.05 vs HSD.
§P0.05 vs HSD Clod.
P0.05 vs DOCA HSD.
¶P(DOCA*Clod)0.05.
758 Hypertension March 2010
 at Vrije on July 11, 2011http://hyper.ahajournals.org/Downloaded from 
buffering mechanism for hypertension via a TonEBP/
VEGF-C regulatory axis.
Discussion
The important finding in our study is that we demonstrate
conversion from a salt-resistant BP state to a salt-sensitive BP
state by depleting MPS cells from the body with Clod. Clod
with LSD had no influence on BP. We also found that the
DOCA-HSD model (without uninephrectomy) was made
even more salt sensitive by depleting MPS cells. Our new
findings in animals given oral 1% saline support the physio-
logical relevance of our recent contention that MPS cells act
as regulators of volume and BP homeostasis via a TonEBP/
VEGF-C regulatory mechanism. We contend that this mech-
anism buffers the development of salt-sensitive hypertension,
either by increased lymph capillary transport capacity of
interstitial fluid or by compensatory increases in eNOS
expression.
We have proposed such a regulatory mechanism previ-
ously; however, the induction of salt-sensitive hypertension
and the regulatory MPS response in that study had been
induced by massive hypertonic salt administration that pos-
sibly had little relevance to established models.12 We now
found that more moderate salt loading by oral 1.0% saline
results in TonEBP expression, which acts as an “osmopro-
tective” gene in skin MPS cells.16,17 The ratio of
(NaK):water, representing 95% of the potentially os-
motically effective cations in the body, was 20% to 26%
higher in skin than in plasma. The finding seems peculiar;
however, we have made similar observations in other models
previously.8–11,13,14 Furthermore, an increase in the skin
Na:water ratio occurred without any changes in plasma
electrolyte concentrations in rats given 1% saline to drink.
This finding indicates that the skin interstitium, in which
MPS cells reside, represents a separate tissue-specific, extra-
cellular microenvironment that is not necessarily represented
by changes in serum electrolyte concentrations. Furthermore,
this state of affairs suggests that extracellular fluids in the
intravascular and interstitial compartments are not invariably
in equilibrium. In the absence of detectable changes in serum
Na and K concentrations, an increased skin Na:water
ratio was paralleled by altered gene expression of the osmo-
protective transcription factor, TonEBP, in skin MPS cells.
This finding indicates that skin Na accumulation leads to
interstitial osmotic stress that initiates a local, MPS-driven,
regulatory response. Our finding that skin Na accumulation
creates an interstitial microenvironment where osmotic stress
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Figure 2. A, Changes in lymph capillary count, MPS cell count,
and VEGF-C pos. cell count in ear. B, Changes in gene expres-
sion of podoplanin, VEGF-C, and TonEBP in the abdominal skin
in the same rats. HSD and DOCA HSD increased both the num-
ber of VEGF-C positive MPS cells in ear and VEGF-C gene
expression in the skin. MPS depletion with Clod left VEGF-C
positive MPS cell count, as well as VEGF-C and TonEBP gene
expression at the control level, despite accumulation of hyper-
tonic saline in the skin. *P0.05 vs LSD; #P0.05 vs LSD Clod;
†P0.05 vs HSD; ‡P0.05 vs HSD Clod, §P0.05 vs DOCA HSD.
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Figure 3. A, Representative Western blot of VEGF-C protein
expression (47 kD) compared with -actin expression (42 kD) in
skin of rats given tap water (LSD) or 1.0% saline (HSD), with or
without additional MPS cell depletion by Clod treatment, with or
without additional DOCA treatment. HSD treatment increased
skin VEGF-C protein expression, and DOCA HSD increased
VEGF-C protein expression in the skin even further. Additional
Clod treatment reversed this effect back to the control level in
both HSD- and DOCA HSD–treated rats. B, Statistical analysis
of VEGF-C protein expression in skin. *P0.05 vs LSD;
#P0.05 vs LSD Clod, †P0.05 vs HSD; ‡P0.05 vs HSD
Clod, §P0.05 vs DOCA HSD.
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is a critical feature of MPS cell function receives support
from Go et al,18 who found that osmotic stress is a critical
feature for lymphatic function. Their data suggest that im-
mune cells residing in the interstitial space, even without
dietary salt loading, confront a microenvironment that is
characterized by hypertonicity compared with plasma. We are
aware that we must develop accurate novel methods to
measure osmolality in these compartments in vivo. However,
in vitro cell-based experiments render support for our
conclusion.12,19
We showed earlier that activation of the TonEBP/VEGF-C
regulatory axis induced hyperplasia of the lymph capillary
network in the skin and increased eNOS protein expression in
interstitial endothelial cells.12 We were able to corroborate
those findings here. In addition, we could show that the
increase in skin eNOS protein expression is not explained by
increased eNOS expression in the lymph capillary network,
because eNOS protein and podoplanin protein as a marker for
lymph-endothelial cells did not colocalize with eNOS expres-
sion. We conclude that increased eNOS protein expression,
which we have shown previously to be MPS and VEGF-C
dependent,12 does not originate from increased lymph endo-
thelial cell mass in the lymph capillary network. This finding
is important, because lymph endothelial cells have the poten-
tial to express eNOS in vitro and in vivo.20–22
MPS cells are diverse and develop into morphological and
functional distinct cell types in response to the tissue micro-
environment. Although MPS cells are uniformly found in
hypertensive target-organ damage lesions, the relative contri-
bution of the MPS cell subsets to the “inflammatory” re-
sponse in atherosclerosis is complex.23–26 Tipping the balance
of macrophage polarization into more proatherogenically
activated M1 subtypes or rather more antiatherogenic pro-
grams in M2 subtypes is considered to affect pathogenesis,
evolution, and complications of target organ damage.25 Our
data provide preliminary evidence that MPS cells may act as
regulators of volume and BP homeostasis in response to
dietary salt loading without inducing a concomitant inflam-
matory response. The findings support the idea that MPS/
TonEBP/VEGF-C activity might represent an “M2 feature”
of MPS cell function. TNF- is a typical indicator for
M1-type polarization of MPS cells. In our rats, MPS cell
infiltration into the skin in response to HSD induced the
TonEBP/VEGF-C regulatory axis without concomitant
TNF- gene and protein expression from the MPS. Further-
more, the BP increase after nonselective MPS blockade with
Clod did not increase TNF- in HSD rats. In contrast,
interstitial MPS infiltration in HSD rats with additional
DOCA treatment, which induces salt-sensitive hypertension
and target organ damage in the long term in the rats, was
paralleled not only by increased TNF- expression but also
led to proteinuria and reproducibly leads to stunted growth
with decreased tissue weights, as shown in the Table and in
our previous studies in DOCA-salt rats.9,13,14 These findings
suggest that DOCA-HSD treatment induces a chronic inflam-
matory state. Interestingly, the TNF- gene in DOCA-HSD
rats remained highly expressed after additional nonselective
MPS depletion with Clod. Moreover, proteinuria worsened
with BP increase, whereas the TonEBP/VEGF-C regulatory
response of the lymph capillary network and eNOS protein
expression were blocked. These findings suggest that MPS
cells contribute to prevent salt-induced hypertension and that
interstitial MPS infiltration may be beneficial by providing a
net protective effect against hypertension-induced target or-
gan damage.
Perspectives
We suggest expanding the horizon of salt-sensitive BP
research to include a third compartment: novel molecular
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Figure 4. A, eNOS protein expression (red) in ears of rats given
tap water (LSD) or 1.0% saline (HSD), with or without additional
MPS cell depletion by Clod treatment, with or without additional
DOCA treatment. HSD and DOCA HSD increased eNOS protein
expression, and additional Clod treatment reversed this effect
back to the control level. B, Colocalization of eNOS protein
expression (red) and podoplanin staining (green) in the same
rats. The increase of eNOS expression observed in HSD and
DOCA HSD rats did not colocalize with the lymphatic endotheli-
um of a lymph capillary (LC). C, Summary of changes in eNOS
protein expression in skin (rat ear). eNOS expression in skin in
response to HSD and/or DOCA HSD treatment was dependent
on MPS activity. *P0.05 vs LSD; #P0.05 vs LSD Clod;
†P0.05 vs HSD; ‡P0.05 vs HSD Clod, §P0.05 vs DOCA HSD.
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regulators, MPS involvement, and local lymph and blood
capillary participation. We present a novel, albeit unconven-
tional, schema featuring MPS cells that modulate BP via
TonEBP/VEGF-C and a vascular bed hitherto fore largely
ignored, namely, the lymphocapillary network. It remains to
be investigated whether the salt-sensitive BP increase that we
found by the acute method of BP measurement in restrained
animals is present in chronically instrumented animals as
well. Radiotelemetric BP measurements may answer this
question and also may provide information on the time course
of the BP increase after experimental MPS depletion. Fur-
thermore, it is tempting to speculate that animals with
VEGF-C overexpression are protected from developing hy-
pertension. Vice versa, it may be speculated that selective
VEGF receptor 3 blockade, a favorite concept in cancer
therapy, may increase BP by blocking MPS regulatory
activity in volume and BP homeostasis. Finally, the fact has
not escaped us that human subject research is required in this
area. Microdialysis techniques and magnetic resonance–
based 23Na methods should be helpful and are areas that we
are pursuing.
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Mononuclear phagocyte system depletion blocks interstitial TonEBP/VEGF-C 
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Online material and methods 
 
Animal experiments. Local government authorities (AZ 54–2531.31–5/07 and TS–
3/07 Med IV / Nephro; Regierung von Mittelfranken, Ansbach; Germany) approved 
the studies and the experiments were done according to the guidelines of the 
American Physiological Society. We randomly assigned 70 male Sprague Dawley 
rats (Charles River, Sulzfeld, Germany) aged 8–9 weeks to 6 groups: Group 1 (n=15) 
and Group 2 (n= 11) to a low–salt diet (LSD; <0.1% NaCl) and tap water. Group 3 
(n=12), Group 4 (n=12), Group 5 (n=10), and Group 6 (n=10) were also fed a low-salt 
chow (<0.1% NaCl), but received salt loading by 0.9% saline water to drink (HSD). 
Groups 5 and 6 were additionally treated with deoxycorticosterone acetate 100 mg 
pellets subcutaneously (DOCA-HSD). To assess the role of mononuclear phagocyte 
system (MPS) cells in the control of volume and blood pressure homeostasis, Groups 
2, 4, and 6 received clodronate liposomes (Clod) i.p. every 72 h for MPS depletion.1, 2 
Two days before the end of the experiment, we placed the rats in a metabolic cage, 
and sampled urine for 24 h. We quantified urinary protein excretion with the Bradford 
assay. At the end of both rat experiments after 2 weeks on their specified diets, we 
anesthetized the rats with 1.5–2% isoflurane anesthesia and catheterized the right 
femoral artery. We connected arterial lines to MLT0380/A transducers and a 
PowerLab 8/30 data acquisition system (ADInstruments, Spechbach, Germany), and 
measured arterial blood pressure (BP) in conscious animals kept in a restrainer 2 h 
after the operation, thereafter, blood samples were taken and the animals were killed 
and skin and ear samples were taken for histology and assessment of protein and 
gene expression. We analyzed arterial blood gases with a clinical blood gas analyzer 
(Radiometer Copenhagen), including Na+, K+, and Cl- measurements by ion-selective 
electrodes. Chemical analysis of the carcasses included Na+, K+, Cl–, and water 
measurements after dry ashing of the different tissues as reported previously.3, 4 
 
Ashing procedure. We completely skinned the carcasses, and removed a 2 g skeletal 
muscle specimen. We weighed the completely skinned rest carcasses and muscle 
specimen [wet weight (WW)], then desiccated at 90°C for 72 h [dry weight (DW)]. 
Because weights were unchanged with further drying, the difference between WW 
and DW was considered as tissue water content. We then ashed the tissues at 190° 
for 5 h, 300°C for 18 h, and 450° C for 24 h and sieved the bones from the carcass 
ashes. We further ashed the separated tissues at 600° C for 48 h and then dissolved 
in 5% or 10% HNO3. We measured Na+ and K+ concentration by atomic adsorption 
spectrometry (Model 3100, Perkin Elmer, Rodgau, Germany), and. Cl- concentration 
by titration with 0.1N silver nitrate (Model Titrando, German Metrohm, Filderstadt, 
Germany). We then calculated Cl- space as a measure of the extracellular volume 
(ECV) from the tissue Cl- content and the serum Cl- concentration: 
  
)/(][
)(
mlmmolClserum
mmolcontentCltissuespaceCltissue −
−
− =     (1) 
We then estimated intracellular volume (ICV) in the tissues was by the Cl--free water 
space: 
   (2) spaceCltissuemlcontentwatertissuespacefreeCltissue −− −= )(
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TonEBP and VEGF-C gene expression. We extracted total RNA from animal tissue 
with RNeasy Minicolumns (Qiagen, Hilden, Germany), homogenizing skin slices 
(~10–20 mg) in 500 µl of RLT buffer reagent with an Ultra-Turrax for 30 s. After 
homogenization, we added 950 µl of water and 16µl of proteinase K (25U/µl), and 
incubated the sample at 55°C for 10 min and then centrifuged at 12,000 rpm for 3 
min. After addition of 1 ml of 96–100% ethanol, we transferred the solvent to the mini-
columns and eluted according to the standard protocol.  
 
Real-time PCR. First-strand cDNA was synthesized with TaqMan RT reagents 
(Applied Biosystems, Darmstadt, Germany), with random hexamers used as primers. 
We performed real-time PCR with an ABI PRISM 7000 sequence detector and SYBR 
green reagents (Applied Biosystems, Darmstadt, Germany) according to the 
manufacturer’s instructions. Primers used for amplification are shown in Table S1. All 
samples were run in duplicate. We normalized the relative amount of the specific 
mRNA of interest with respect to 18S rRNA content in the sample. Dissociation 
curves confirmed the specificity of the PCR. 
 
Table S1. Real time PCR primers 
Primer Sequence 
Rat TNF-α 
Forward 
Reverse 
Rat TonEBP 
Forward 
Reverse 
Rat VEGF-C 
Forward 
Reverse 
 
Ribosomal 18S Primers 
Forward 
Reverse 
 
GCCCAGACCCTCACACTC 
CCACTCCAGCTGCTCCTC 
 
CCAATGGAAGTAACATCAGAGAAA 
CTGGGTTGATCCGACTGTCT 
 
TCCACCATCAAACATGCAGC  
TCAGTCGATTTGTACATGGTCGT 
 
 
TTGATTAAGTCCCTGCCCTTTGT 
CGATCCGAGGGCCTCACTA 
 
 
 
VEGF-C protein expression. We homogenized matrix proteins from shock-frozen skin 
in 500µl lysis buffer (50 mM Tris_HCl, pH 7.2, 150 mM NaCl, 1% Triton X-100, 1 mM 
sodium orthovanadate, 50 µg/ml sodium pyrophosphate, 100 mM sodium fluoride, 
0.01% aprotinin, 4 µg/ml pepstatin A, 10 µg/ml leupeptin, and 1 mM 
phenylmethylsulfonyl fluoride) with an Ultra-Turrax for 30sec. 
For immunoblotting, we separated equal amounts of total protein on 8% or 
12% SDS-polyacrylamide gel under reducing conditions and electroblotted onto a 
polyvinylidene diflouride (PVDF) membrane. We blocked the blots with 5% nonfat 
milk in phosphate buffered saline (PBS) and 0.1% Tween 20, pH 7.5 for 1 h at room 
temperature and then incubated overnight at 4°C with Anti-VEGFC (Abcam, 
Cambrigde, UK). Equal amounts of protein were run on 8% SDS-polyacrylamid gels. 
After three washes in PBS with 0.1% Tween20 pH7.5, the we incubated the blots for 
1 h with horseradisch peroxidase-conjugated anti-rabbit IgG (Pierce, Rockford, USA) 
diluted 1:2,000 in blocking solution at room temperature. We visualized antibody 
binding using an enhanced chemiluminescence system (Pierce, Rockford, USA). We 
scanned specific bands and quantified them by densitometry. 
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TNFα Elisa. TNFα Elisa was from Abcam (Cambridge, UK) and was performed 
according to manufacturer’s instructions. 
 
Immunhistochemistry and immunofluorescence staining of lymphcapillaries. We fixed 
animal tissues in 5% formalin and embedded in paraffin. We performed all staining 
using Avidin/Biotin Blocking Kit (Vector laboratories) and HRP super staining kit (ID 
Labs, Ontario, USA) according to manufacturer’s instructions. Briefly, we 
deparaffinised slides and boiled two times for about 5 min at 600 W in a microwave in 
0.1 M citrate buffer (pH 6.0). We cooled down the slides to room temperature and 
incubated in 3% H2O2 for 10 min. We then blocked the slides with Avidin/Biotin 
Blocking Kit (Vector laborities, Burlingame, USA) according to manufacturer’s 
protocol and with SuperBlock for about 7 min. After three times washing with PBS, 
we incubated slides with first antibody for about 1 h, followed by incubation with the 
polyvalent antibody and HRP for 10 min. We washed the slides three times with PBS 
between every step. We detected specific staining using AEC Chromogen/Substrate 
(3-Amino-9-ethylcarbazole , ID Labs). Both lymph capillaries and MPS cells were 
counted throughout the whole diameter of a crosswise cut rat ear. We counted lymph 
capillaries counted at 125-fold amplification, and MPS cells at 300-fold amplification 
under the microscope. Starting from the same edge of the ear, we counted lymph 
capillaries in 5 consecutive fields, as indicated in Figure S1. Similarly, we counted  
 
 
125x field
300x fields
 
 
Figure S1: Scheme of sections for lymph capillary counting (125-fold field) and for MPS counting (300-fold field). 
 
MPS cells in 6 consecutive sections and normalized capillary and MPS cell counts 
per field. For three-dimensional reconstruction, we fixed and stained 143 7µm-sized 
serial sections of ear specimens for podoplanin as described above. We performed 
digitalization of the serial slices using an AxioCam MRm camera (Zeiss, Germany) 
mounted on an Axiovert 200M microscope (Zeiss, Germany) with the fluorescence 
filter for Cy2 (filter set 38 HE, Zeiss). After acquisition, a stack of equal image size 
was built using the graphic tool ImageJ (Wayne Rasband, NIH, Bethesda, MD, USA).  
We imported the equalized data into the Amira 4.1 visualization software (Visage 
Imaging Inc., Carlsbad, California, USA) on a Dell Precision 690 computer system 
(Dell, Frankfurt, Germany). After this step, the podoplanin channel was aligned. In the 
segmentation step the podoplanin data set served as a scaffold and was spanned 
manually or automatically using greyscale values. Out of this segmentation matrix we 
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generated the volume surfaces. We reconstructed the surfaces of skin and cartilage 
using the fluorescence of the background-staining of the podoplanin antibody. 
Antibody dilutions: Anti-Podoplanin 1:5,000 (from D. Kerjaschki), Anti-VEGFC 
1:1,000 (Abcam, Cambrigde, UK). 
 
Immunofluorescence staining of eNOS expression. Paraffin-embedded sections were 
dewaxed, dehydrated and antigen-demasked with 0.05% trypsin. We performed 
indirect immunofluorescence for expression of eNOS with a rabbit polyclonal anti-
eNOS antibody (ABR, Affinity Bio reagents, CO, USA). We blocked nonspecific 
binding sites with 10% normal donkey serum (Jackson ImmunoResearch 
Laboratories, PA, USA) for 30 min in room temperature. Thereafter we incubated 
sections with the primary antibody  for 1 h. All incubations were performed in a humid 
chamber at room temperature. For fluorescent visualization of bound primary 
antibodies, we further incubated sections with Cy3-conjugated donkey anti-rabbit 
antibody (Jackson ImmunoResearch Laboratories, PA, USA) for 1 h in the dark. We 
analyzed specimens using a Zeiss Axioplan-2 imaging microscope with the digital 
image-processing program AxioVision 4.3 (Zeiss, Jena, Germany). Semiquantitative 
analysis of eNOS expression was done by using the following scoring system: 0, 
absent; 1, very few; 2, few; 3, mediate; 4, much and 5, very much expression. We 
analyzed 10 areas per section in 5-6 rats from each group.  The investigator 
performing these immunohistochemical analyses had no knowledge of the treatment 
group assignment. 
 
 
Statistical analysis. Comparison of means of data from animal experiments was 
calculated by multivariate or univariate analysis using the General Linear 
Measurements (GLM) procedure. We tested for the effect of diet, clodronate 
treatment, and adenoviral transfer of soluble VEGFR receptor. Comparison of means 
in cell culture experiments was calculated by Student’s T-test for paired samples. All 
data in the manuscript are presented as average ± SD. The term increased or 
decreased are used only if the results were significant at P<0.05. Statistical analysis 
was performed with the SPSS software (version 15.0). 
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Figure S2: 
MPS cells visualized with a CD68-specific antibody in ear of rats given tap water (LSD) or 
1.0% saline (HSD), with or without additional macrophage depletion by Clod treatment, with 
or without additional DOCA treatment. HSD and DOCA HSD increased MPS cell count, and 
additional Clod treatment reversed this effect towards control level. 
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Figure S3: 
Lymphatic capillaries, visualized with a podoplanin-specific antibody in ear of rats given tap 
water (LSD) or 1.0% saline (HSD), with or without additional macrophage depletion by Clod, 
with or without additional DOCA treatment. HSD and DOCA HSD increased lymph capillary 
count, and additional Clod treatment reversed this effect back to the control level. 
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